Embryonic stem cells and self-renewal I Flashcards
What study highlighted the carcinogenesis of stem cells?
The study of teratomas in strain 129 mice (mice that produce this tumour)
What is a teratoma?
A large tumour that gives rise to many different tissues (eg. hair, bone, nerves)
Very differentiated tissues from different origins
Sometimes in an organised way
What are cancerous teratomas called?
Teratocarcinomas
What did Kleinsmith et al show in 1964?
How?
The complexity of the tissues in the teratoma can be originated to a single cell (pluripotent cells - produces the different tissues of the different germ layers)
Using clonal experiments:
- Take single cell from animal with the tumour and put into another animal –> recreates the tumour
What are embryonic carcinoma (EC) cells?
What do they resemble?
How was this shown?
The stem cells of the teratocarcinomas
Resemble true pluripotent embryonic cells
Shown by transplanting EC cells (from a pigmented animal) into the blastocyst of an albino mouse
–> cells contribute to the whole developing animal
What did the independent work of Evans and Martin in 1981 show?
How?
What did they show?
- The ability to isolate and characterise truly pluripotent cells from the developing mouse by using the knowledge acquired from working with EC cells (how to culture and manipulate them
- Showed that mouse ES cells grow better on a layer of feeder cells
What are feeder cells?
- Support cells (eg. fibroblasts) that condition the media to support the growth of the stem cells
- They are INACTIVATED with a drug or radiation that stop them from dividing
Where are ES cells extracted from?
From the inner cell mass of the blastocyst
What tests are used to see if a cell is truly pluripotent?
1) Creation of a teratoma when the cells injected into the mouse
2) If inject into the blastocyst of a mouse embryo –> contributes to the different tissues in that animal
What tissues should a pluripotent stem cell be able to give rise to?
All of the different cells and germ layers, including the germ cells (sperm and egg)
What are the 9 properties of an ES cell?
1) Derived from the ICM of a blastocyst
2) Non-transformed (normal)
3) Indefinite proliferative potential (immortal)
4) Stable diploid karyotype
5) Clonogenic
6) Pluripotent
7) Incorporation into chimaeras (contribution to the cells of many different tissues)
8) Germline transmission into chimeras
9) Permissive to genetic manipulation (eg. KO, replace mutated genes, over-express genes)
What can happen to ES cells as they are extensively cultured in vitro?
Why is this a problem?
They can acquire abnormalities in the genome
A problem because ES cells must be non-transformed and have a stable diploid karyotype
What does clonogenic mean?
Can originate a culture from a single cell
What are the issues when determining hES using the properties of ES cells?
- Difficult to achieve a stable diploid karyotype
- Difficult to clone hES from single cells
- Cannot test the contribution to all the different cell types in vivo (eg. contribution to the gametes)
- Not practical to test the incorporation of the stem cells into chimeras due to ethical considerations
To what extent has chimerism with hES been demonstrated?
hES into the mouse blastocyst
What happens when inject mouse ES cells into a blastocyst?
How is this seen?
The cells will incorporate into all embryonic cell types:
- Seen when looking at a mouse foetus produced form ES cells where one of the copies of a particular gene (of the ES cells) is replaced with an enzyme (eg. beta-galactoside)
How is beta-galactoside used?
As a reporter gene:
- Turns blue when the right substrate is added
- Can see where the gene is expressed
(Used to visualise ES cells that have it incorporated into the genome of the cell)
How can you create a transgenic mouse?
By genetically manipulating ES cells that are incorporated into the animal
What are the extrinsic factors that allow us to maintain cells in their pluripotent, proliferative state?
LIF (Leukaemia Inhibitory Factor)
Where is LIF secreted from?
Initially from the feeder cells
What happens when LIF is withdrawn?
Proliferation continues but DIFFERENTIATION is induced
Describe the LIF pathway
- LIF interacts with the LIF receptor (LIFR) that combines with Gp130 (glycoprotein co-receptor)
- LIFR and corresponding Gp130 will activate the JAK pathway
- JAK pathway upregulates STAT3 (that is critical to maintain the proliferative state of the cell)
As well as the LIF pathway, what other pathway does LIF act on?
Describe this pathway
The SHP2 pathway:
- LIF binds to the LIFR (with co-receptor Gp130) –> causing the activation of SHP2
- SHP2 activates ERK1/2 (a kinase)
- ERK1/2 then blocks STAT3 (therefore blocking self-renewal/pluripotency) and ACTIVATES proliferation/differentiation
Describe the balance between the LIF and the SHP2 pathways
Balance between the 2 (self-renewal and differentiation) is critical
- HOWEVER, the LIF and SHP2 pathways are not evenly balanced
- In the absence of LIF (not activating either pathway) –> differentiate
- LIF above a certain THRESHOLD –> force the cells to self-renew
When is the ONLY time LIF drives self-renewal in mES cells?
When grown in SERUM
in serum-free conditions, LIF alone is INSUFFICIENT to maintain pluripotency or block neural differentiation
What is needed in serum-free conditions to sustain self-renewal and pluripotency?
LIF and BMP4 (or BMP2)